Innovent Biologics, Inc. (1801.HK) HKSE
87.05
-1.65(-1.86%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
87.05
-1.65(-1.86%)
Currency In HKD
| Market Cap | 114.89B |
| Enterprise Value | 100.35B |
| P/E Ratio | 84.26 |
| PEG Ratio | 0.1 |
| Price/Sales Ratio | 10.13 |
| Price/Book Ratio | 3.54 |
| Enterprise/Revenue | 9 |
| Enterprise/EBITDA | 72.36 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.06 |
| Operating Margin | 0.11 |
| Return On Assets | 0.02 |
| Return On Equity | 0.05 |
| Revenue | 12.7B |
| Revenue/Share | 14.22 |
| Gross Profit | 10.99B |
| EBITDA | 1.97B |
| Net Income | 792.51M |
| Diluted EPS | 0.46 |
| Total Cash | 18.24B |
| Total Cash/Share | 20.07 |
| Total Debt | 2.82B |
| Total Debt/Equity | 0.15 |
| Current Ratio | 2.62 |
| Book Value Per Share | 22.18 |
| 52-Week Change | 74.1 |
| 52-Week High | 109.1 |
| 52-Week Low | 49.05 |
| Moving Average 50 Days | 86.21 |
| Moving Average 200 Days | 88.88 |
| Average Volume | 11.66M |
| Shares Outstanding | 1.73B |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |